TLSI (TriSalus Life Sciences, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
TriSalus Life Sciences, Inc. Common Stock (TLSI) is a publicly traded Healthcare sector company. As of May 21, 2026, TLSI trades at $3.27 with a market cap of $186.09M and a P/E ratio of -1.75. TLSI moved +2.70% today. Year to date, TLSI is -46.97%; over the trailing twelve months it is -39.66%. Its 52-week range spans $2.20 to $7.95. Analyst consensus is strong buy with an average price target of $8.80. Rallies surfaces TLSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns TLSI stock?
Hedge funds tracked by Rallies that own TLSI include Duquesne Family. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for TriSalus Life Sciences, Inc. Common Stock.
TLSI Key Metrics
Key financial metrics for TLSI
Metric
Value
Price
$3.27
Market Cap
$186.09M
P/E Ratio
-1.75
EPS
$-1.84
Dividend Yield
0.00%
52-Week High
$7.95
52-Week Low
$2.20
Volume
359
Avg Volume
0
Revenue (TTM)
$45.15M
Net Income
$-39.23M
Gross Margin
84.57%
Top Hedge Funds Holding TLSI
Duquesne Family holds 426.92K shares of TLSI, changed +0.00% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own TLSI include Duquesne Family. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for TriSalus Life Sciences, Inc. Common Stock.
Does Rallies show 13F holders for TLSI?
Yes. Rallies tracks hedge fund and 13F ownership data for TLSI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TLSI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TLSI. It does not provide personalized investment advice.
